Using biomaterial-based 3D in vitro cancer models to solve current clinical problems.

Area of Science:

• Biomaterials Science
• Cancer Biology
• Preclinical Research

Background:

• Cancer progression involves complex cellular and acellular interactions.
• Current preclinical models (2D cultures, animal models) have significant limitations, including cost, time, and accuracy.
• Biomaterials can create advanced 3D in vitro models that better recapitulate the tumor microenvironment.

Purpose of the Study:

• To review the role of biomaterial-based 3D in vitro models in cancer research.
• To highlight how these models address limitations of existing preclinical approaches.
• To bridge the gap between current research and potential clinical impact.

Main Methods:

• Utilizing tuneable, biocompatible materials like hydrogels as scaffolds.
• Seeding cancer cells and other components to mimic tumor extracellular matrix.
• Developing 3D in vitro models that replicate key aspects of the tumor microenvironment.

Main Results:

• Biomaterial-based 3D models effectively mimic the tumor microenvironment.
• These models show promise for drug screening and investigating treatment responses.
• Demonstrated capability to model cancer progression mechanisms.

Conclusions:

• Biomaterial-based 3D in vitro models represent a significant advancement in cancer research.
• These models offer a more accurate and efficient platform compared to traditional methods.
• Potential to accelerate the development of novel cancer treatments and improve clinical outcomes.